Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
TRPV4 channels are essential for alveolar epithelial barrier function as protection from lung edema
Jonas Weber, … , Thomas Gudermann, Alexander Dietrich
Jonas Weber, … , Thomas Gudermann, Alexander Dietrich
Published September 15, 2020
Citation Information: JCI Insight. 2020;5(20):e134464. https://doi.org/10.1172/jci.insight.134464.
View: Text | PDF
Research Article Cell biology Pulmonology

TRPV4 channels are essential for alveolar epithelial barrier function as protection from lung edema

  • Text
  • PDF
Abstract

Ischemia/reperfusion-induced edema (IRE), one of the most significant causes of mortality after lung transplantation, can be mimicked ex vivo in isolated perfused mouse lungs (IPL). Transient receptor potential vanilloid 4 (TRPV4) is a nonselective cation channel studied in endothelium; however, its role in the lung epithelium remains elusive. Here, we show enhanced IRE in TRPV4-deficient (TRPV4–/–) IPL compared with that of WT controls, indicating a protective role of TRPV4 in maintenance of the alveolar epithelial barrier. By immunohistochemistry, mRNA profiling, and electrophysiological characterization, we detected TRPV4 in bronchial epithelium, alveolar epithelial type I (ATI), and alveolar epithelial type II (ATII) cells. Genetic ablation of TRPV4 resulted in reduced expression of the water-conducting aquaporin-5 (AQP-5) channel in ATI cells. Migration of TRPV4–/– ATI cells was reduced, and cell barrier function was impaired. Analysis of isolated primary TRPV4–/– ATII cells revealed a reduced expression of surfactant protein C, and the TRPV4 activator GSK1016790A induced increases in current densities only in WT ATII cells. Moreover, TRPV4–/– lungs of adult mice developed significantly larger mean chord lengths and altered lung function compared with WT lungs. Therefore, our data illustrate essential functions of TRPV4 channels in alveolar epithelial cells and in protection from edema formation.

Authors

Jonas Weber, Suhasini Rajan, Christian Schremmer, Yu-Kai Chao, Gabriela Krasteva-Christ, Martina Kannler, Ali Önder Yildirim, Monika Brosien, Johann Schredelseker, Norbert Weissmann, Christian Grimm, Thomas Gudermann, Alexander Dietrich

×

Figure 1

Ablation of TRPV4 increases ischemia-induced edema formation in mouse lungs.

Options: View larger image (or click on image) Download as PowerPoint
Ablation of TRPV4 increases ischemia-induced edema formation in mouse lu...
(A) TRPV4 protein expression in mouse lungs was evaluated by immunoblotting in whole-lung lysates of WT and TRPV4-deficient (TRPV4−/−) mice using a TRPV4-specific antiserum. Murine embryonic fibroblasts (MEFs) served as an additional positive control. β-Actin was used as loading control. (B) Constant weight measurement of ischemic and nonischemic WT and TRPV4–/– and TRPV4/TRPC6 double-deficient (TRPV4/TRPC6–/–) isolated perfused lungs. (C) Representative images of WT and TRPV4–/– lungs after ischemia. (D) Wet-to-dry weight ratio gains of TRPV4–/– and TRPV4/TRPC6–/– lungs compared with those of WT controls. Data represent mean ± SEM of at least 5 lungs for each genotype. Significance between means was analyzed using ANOVA (B and D); ***P < 0.001.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts